Resverlogix is currently being covered by the following analysts:
Claude Camiré, Biotech & Healthcare Analyst, Paradigm Capital in Toronto, ON.
Christopher S. James, M.D., Managing Director & Senior Healthcare Equity Analyst, MLV - McNicoll, Lewis & Vlak in New York, NY.
